Is Stone-free Status After Surgical Intervention for Kidney Stones Associated With Better Health-related Quality of Life? - A Multicenter Study From the North American Stone Quality of Life Consortium.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
02 2021
Historique:
received: 20 04 2020
revised: 16 09 2020
accepted: 21 09 2020
pubmed: 9 12 2020
medline: 27 1 2022
entrez: 8 12 2020
Statut: ppublish

Résumé

To compare the health-related quality of life (HRQOL) of patients with residual fragments after surgical intervention for kidney stones to patients that are stone-free using the disease-specific Wisconsin stone quality of life (WISQOL) questionnaire. Kidney stones contribute to impaired HRQOL, which is increasingly recognized as an important healthcare outcome measurement. With institutional review board approval, 313 adult patients who underwent surgical intervention for kidney stones at 4 sites completed a WISQOL questionnaire. We retrospectively collected surgical data including presence of residual fragments on post-operative imaging. We calculated standardized WISQOL total and domain scores (0-100), which included items related to social functioning (D1), emotional functioning (D2), stone-related impact (D3), and vitality (D4). Scores were compared between patients with residual fragments to those who were stone-free after surgical intervention. Demographics did not differ between groups, overall mean age 54.6 ± 13.5 and 55.4% female. There was no significant difference in total WISQOL score for patients with residual fragments (n = 124) compared to patients that were stone-free (n = 189), 110.5 ± 27.8 vs 115.4 ± 23.6 respectively, (P = .12). Interestingly, patients with residual fragments who underwent secondary surgery were found to have significantly lower total WISQOL score (88.4 ± 30.1 vs 116.6 ± 25.0, P <.0001). Stone-free status after surgical intervention is not associated with better HRQOL when compared with patients whose surgeries left residual fragments. Indeed, further surgical intervention on residual fragments to achieve stone-free status may actually result in worse HRQOL.

Identifiants

pubmed: 33290774
pii: S0090-4295(20)31433-3
doi: 10.1016/j.urology.2020.09.058
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-82

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Necole M Streeper (NM)

Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA. Electronic address: nstreeper@pennstatehealth.psu.edu.

Matthew Galida (M)

Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA.

Suzanne Boltz (S)

Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA.

Shuang Li (S)

Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Stephen Y Nakada (SY)

Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Eric P Raffin (EP)

Department of Urology, Dartmouth Hitchcock Medical Center, Lebanon, NH.

David R Brown (DR)

Department of Urology, Dartmouth Hitchcock Medical Center, Lebanon, NH.

Vernon M Pais (VM)

Department of Urology, Dartmouth Hitchcock Medical Center, Lebanon, NH.

Justin Y H Chan (JYH)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Kymora B Scotland (KB)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Ben H Chew (BH)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Kristina L Penniston (KL)

Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH